1. Agarwal M, Shenjere P, Blewitt RW, et al. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa: an indolent lesion: report of 4 cases. Int J Surg Pathol. 2008; 16:286–90.
2. Sciallis AP, Law ME, Inwards DJ, et al. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders. Mod Pathol. 2012; 25:983–92.
Article
3. Wang W, Cai Y, Sheng W, Lu H, Li X. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014; 117:96–104.
Article
4. Erõs N, Marschalkó M, Lõrincz A, et al. CD30-positive anaplastic large T-cell lymphoma of the tongue. J Eur Acad Dermatol Venereol. 2009; 23:231–2.
Article
5. Tang TT, Glicklich M, Hodach AE, Oechler HW, McCreadie SR. Ulcerative eosinophilic granuloma of the tongue: a light- and electron-microscopic study. Am J Clin Pathol. 1981; 75:420–5.
Article
6. Ficarra G, Prignano F, Romagnoli P. Traumatic eosinophilic granuloma of the oral mucosa: a CD30+(Ki-1) lymphoproliferative disorder? Oral Oncol. 1997; 33:375–9.
7. Alobeid B, Pan LX, Milligan L, Budel L, Frizzera G. Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa: a form of “traumatic eosinophilic granuloma”. Am J Clin Pathol. 2004; 121:43–50.
8. Salisbury CL, Budnick SD, Li S. T-cell receptor gene rearrangement and CD30 immunoreactivity in traumatic ulcerative granuloma with stromal eosinophilia of the oral cavity. Am J Clin Pathol. 2009; 132:722–7.
Article
9. Segura S, Romero D, Mascaró JM Jr, Colomo L, Ferrando J, Estrach T. Eosinophilic ulcer of the oral mucosa: another histological simulator of CD30+ lymphoproliferative disorders. Br J Dermatol. 2006; 155:460–3.
10. Hirshberg A, Amariglio N, Akrish S, et al. Traumatic ulcerative granuloma with stromal eosinophilia: a reactive lesion of the oral mucosa. Am J Clin Pathol. 2006; 126:522–9.
11. Abdel-Naser MB, Tsatsou F, Hippe S, et al. Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation? Dermatology. 2011; 222:113–8.
12. Cho EY, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J Korean Med Sci. 2008; 23:185–92.
Article
13. Wang RC, Chang ST, Hsieh YC, et al. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Int J Clin Exp Pathol. 2014; 7:2430–7.
14. Park S, Ko YH. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders. J Dermatol. 2014; 41:29–39.
Article
15. Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008; 58:209–17.
Article
16. Park BM, Ahn JS, Lee JB, Won YH, Yun SJ. Chronic active EpsteinBarr virus infection-associated hydroa vacciniforme-like eruption and Behcet’s-like orogenital ulcers. Dermatology. 2013; 226:212–6.
17. Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES. EBV positive mucocutaneous ulcer: a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010; 34:405–17.